Scope an Engagement
Fractional Quality Management

Clinical-stage governance for life sciences

Embedded senior leadership calibrated to your developmental phase transitions from IND through Phase III, ensuring rigorous GxP compliance without headcount overhead.

21 CFR

Part 11 validation protocols

GxP

Audit readiness systems

100%

Inspection defense record

Core Capabilities

Systematic quality architecture

Audits

Rigorous vendor qualification and CMO audit governance

Eliminate supply-chain compliance risk through rigorous vendor qualification, analytical laboratory oversight, and active contract manufacturing organization audit governance.

SOPs

SOP architecture and lifecycle document control

We sit inside your operational cadence to author, review, and deploy Standard Operating Procedures that withstand intense regulatory scrutiny during pre-approval inspections.

eQMS

Electronic quality management system deployment

Implement validated digital systems for deviation tracking, CAPA management, and change control fully aligned with data integrity mandates and electronic record rules.

Deployment Framework

Four-stage regulatory defense model

01
02
03
04

Initial Gap Assessment

Infrastructure Design

Embedded Execution

Inspection Readiness

Comprehensive evaluation of existing quality systems, data integrity protocols, and regulatory exposure prior to IND submission.

Rapid drafting of GxP-compliant SOPs, validation master plans, and vendor oversight procedures tailored to trial milestones.

A battle-tested Head of Quality integrates directly into your operational cadence to manage QA/QC and clinical data review.

Mock regulatory audits and continuous compliance monitoring designed to ensure flawless defense during FDA or EMA evaluation.

Scope an Engagement

Request a targeted regulatory gap review

Connect with our fractional quality leadership to align your upcoming trial milestones with inspection-ready systems.